RESECTABLE HEPATOCELLULAR CARCINOMA

Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2

New drug combo tested to shrink liver tumors before surgery

Disease control Not yet recruiting

This early-stage study is testing whether two drugs, ateganosine and cadonilimab, can help shrink liver tumors before surgery. The goal is to see if this approach makes the subsequent surgical removal more effective and is safe for patients. Participants will be randomly assigned…

Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA

Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control

Last updated Apr 01, 2026 21:26 UTC

RESECTABLE HEPATOCELLULAR CARCINOMA

Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear

New drug combo tested to shrink liver tumors before surgery